Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. - Wikidata - awgldk - TriplyDB

Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.

Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.

http://www.wikidata.org/entity/Q38112711

about

Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy Presence and Risk Factors for Glaucoma in Patients with Diabetes.Comparison of spectral-domain optical coherence tomography for intra-retinal layers thickness measurements between healthy and diabetic eyes among Chinese adults The alternative complement pathway regulates pathological angiogenesis in the retina Effect of ranirestat, a new aldose reductase inhibitor, on diabetic retinopathy in SDT rats.Spare the rods and spoil the retina: revisited Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.Neurovascular crosstalk between interneurons and capillaries is required for vision.The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema.Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects.Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective.Niaspan inhibits diabetic retinopathy‑induced vascular inflammation by downregulating the tumor necrosis factor‑α pathway.Nerve growth factor in diabetic retinopathy: beyond neurons.Role of endocannabinoids in the progression of diabetic retinopathy.Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes.Diabetic retinopathy is a neurodegenerative disorder.Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration.Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability: diabetic milieu makes a difference.Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.Recent advances in the management and understanding of diabetic retinopathy.Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.Quantitative Analysis and Biological Efficacies regarding the Neuroprotective and Antineuroinflammatory Actions of the Herbal Formula Jodeungsan in HT22 Hippocampal Cells and BV-2 Microglia.Retinal oxidative stress at the onset of diabetes determined by synchrotron FTIR widefield imaging: towards diabetes pathogenesis.Cerebrolysin reverses hippocampal neural atrophy in a mice model of diabetes mellitus type 1.Diabetes induces changes in neuroretina before retinal vessels: a spectral-domain optical coherence tomography study.Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases.The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury.

P2860

Q26745555-FAF5D226-FCC7-4716-A4C1-61EEE035D380 Q28078199-8C13054B-69EE-428C-B45B-3D7EF0BB32CB Q30244246-FE9DC9E8-AB5E-4942-AEAA-D772F8E2975F Q33664188-41D8D3F2-75A8-42C9-A713-DA67BD6CFB21 Q33775122-98EFDA09-2B47-4922-8B37-85832E350217 Q34152215-4BF5D7CA-C10C-45E7-8587-7166F01C946C Q34504721-9E39CA68-8857-4554-951D-6BBA4D529550 Q34523578-B2A596DE-A9A9-4FE6-8F67-76E28C11D6F8 Q35836151-277C5C60-D3E2-4B77-8B2B-34075CD7DCEC Q35859558-8DBE586F-3353-48E7-AF71-5D68D1045AA7 Q35882571-49534A2F-E02D-4677-B1E4-E6BB467B7E90 Q36025923-B2CCB99C-7B51-42AB-851B-B7EDC1297CE3 Q36379507-CF30EB29-60A8-490C-A49D-FF9FC18FF91A Q37677024-4AD1C134-E7E3-436C-BE98-13FBABD2C930 Q37722105-9C3FD8C0-F0EE-4B71-BD8A-C8433EC459FA Q38230380-3C514816-6576-45B5-9DC5-C2C87C919AF1 Q38588418-02A9B5A9-0348-4776-80EB-1577572FB887 Q38608755-8506345F-EB05-492A-AC85-41349FD6E072 Q38730604-43A4560C-9532-41AC-ADC2-FA2DFF4E907C Q38913007-E86234E8-F779-4DDB-9DF5-3AFA1D49DF11 Q39357651-761D648B-0FF3-4714-BABB-52CBAC4E6D8C Q41049002-3F36ECA5-A87D-45A0-B619-74FE2F78DA4C Q42375985-E9A7D6F6-39B6-43FE-9D03-DE83A25D0A33 Q43244563-B6F64507-4CFE-43C4-880B-40F592121659 Q47168388-1F96E0C1-A148-4205-9C01-426DB9585701 Q47710677-19D6490B-6456-4963-ABBA-BB1DC56AE61B Q48119834-A6EEC72D-4D1A-4DB8-A19F-1769A0E80682 Q48225278-41FC6570-63B2-4818-B806-F4A9397DBB13 Q48241954-B0DE4EC5-C483-4A70-AB33-D8B9F0C4DAB5 Q53722103-F7FE1F75-18EB-4B51-88CD-DA57DF6647FB Q55031516-6B9B6EDE-1809-4C87-9B16-27B4A97CF83B Q55395409-E4A93289-1247-4D03-8EA6-EE3C64C26CD7

P2860

Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.

http://www.wikidata.org/entity/Q38112711

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Neurodegeneration in the patho ...... and therapeutic implications.

@en

type

label

Neurodegeneration in the patho ...... and therapeutic implications.

@en

prefLabel

Neurodegeneration in the patho ...... and therapeutic implications.

@en

P1433

Q38112711-A10E8958-688D-4798-8779-75C9E1E0A088

P1476

Q38112711-8F87A14C-631B-4D31-A9B4-E267D8129487

P2093

Q38112711-9146383D-CD8A-4BFE-9033-3E21D4423B97

Q38112711-C6A10D44-CB42-431F-8F9A-E24F891E7681

P2860

Q38112711-014BE876-69AC-4141-A4CA-2CE2B2F7464D

Q38112711-05027D1B-A224-4DFC-8035-34302BDEDA75

Q38112711-050F7C8A-A88A-418D-8AE2-704CCF1E0FBE

Q38112711-0581827D-E673-443E-A2B9-AC6399A860EC

Q38112711-06C360A4-54FF-4675-99B4-2D5EDC3BF204

Q38112711-07E0974A-855A-4FB7-BAE3-B8897BE1E4D4

Q38112711-0E97D6FE-51D9-40B3-8507-848036091375

Q38112711-11A90DCA-CCCB-49C7-90DF-2BC096C2AED0

Q38112711-19966BB2-8837-4DC6-9832-E1C24281AD55

Q38112711-1A263D92-28C8-49D8-A968-DAE0F984E41E

P304

Q38112711-9DDC2377-E703-4136-B571-6F5741097483

P31

Q38112711-AB4C4A15-4136-462F-B173-B6C69E85050C

P356

Q38112711-B1C55A21-10B0-4191-B5EB-9A0D82B0CE06

P433

Q38112711-C4BED339-2696-4DD9-9627-FC7D2E9DD7DB

P478

Q38112711-38EB9320-9E3C-4BDE-BA22-4A1DC464430F

P577

Q38112711-95EECED4-73DE-42F9-9431-BCF0A76298A7

P698

Q38112711-388ABE15-D59C-4558-B2BE-A876FFD24BC0

P921

Q38112711-340AE38F-5D60-4CC7-9C71-B02536EE9D6A

P932

Q38112711-D13E81FD-4AF0-4939-8C3A-980E28C53386

P356

09298673113209990027

P1433

Current Medicinal Chemistry

P1476

Neurodegeneration in the patho ...... and therapeutic implications.

@en

P2093

Maxwell S Stem

http://www.w3.org/2001/XMLSchema#string

Thomas W Gardner

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Inflammation and metabolic disorders

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens

Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance

Effects of intensive glucose lowering in type 2 diabetes

P304

3241-3250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/09298673113209990027

http://www.w3.org/2001/XMLSchema#string

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23745549

http://www.w3.org/2001/XMLSchema#string

P921

P932

4071765

http://www.w3.org/2001/XMLSchema#string